Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention of pertussis using adenylate cyclase deficient Bordetella strains

Prevention of pertussis using adenylate cyclase deficient Bordetella strains

US Patent 10046044 · Granted Aug 14, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bordetella strains expressing serotype 3 fimbriae2025
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology2023
Bordetella strains expressing serotype 3 fimbriae2022
Attenuated Bordetella strains2022
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology2021
Mutant Bordetella strains and methods of use2021
Mutant Bordetella strains and methods of use2020
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology2020
Attenuated Bordetella strains2020
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology2019
Prevention of pertussis using adenylate cyclase deficient Bordetella strains2019
Prevention of pertussis using adenylate cyclase deficient Bordetella strains2019